Drug profile · INN
bimekizumab-bkzx
BIMZELX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bimekizumab-bkzx (BIMZELX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN bimekizumab-bkzx
Brand BIMZELX
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is bimekizumab-bkzx?
bimekizumab-bkzx (BIMZELX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for bimekizumab-bkzx?
BIMZELX is a marketed brand name for bimekizumab-bkzx. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bimekizumab-bkzx?
bimekizumab-bkzx has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.